DSP Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
DSP Healthcare Fund - Regular Plan - Growth
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹227 Cr | ₹3074 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 08 Nov 2021 | 30 Nov 2018 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 18% |
| Expense Ratio | 2.35 | 1.9 |
| Manager | Rohan Korde | Jay Kothari |
| ISIN Code | INF00XX01BL5 | INF740KA1LD8 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | DSP Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Month | 3.06% | 1.51% |
| 6 Month | 4.04% | 7.17% |
| 1 Year | -2.79% | -2.79% |
| 3 Year | 18.71% | 20.98% |
| 5 Year | - | 17.92% |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 6 Month | 1.79% | 0.06% |
| 1 Year | 4.26% | 0.78% |
| 3 Year | 17.98% | 17.52% |
| 5 Year | - | 16.88% |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Year | 18.94% | 25.18% |
| 3 Year | 20.21% | 21.14% |
| 5 Year | - | 26.06% |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Standard Deviation | 15.64% | 14.63% |
| Sharp | 0.77% | 0.98% |
| Beta | 0.95% | 0.84% |
| Alpha | -2.74% | 1.19% |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Name | Rohan Korde | Jay Kothari |
| Total AUM | ₹4626 Cr | ₹0 Cr |
| Funds Managed | 10 | 20 |
| ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 3.56 | 15.67 |
| Large Cap | 29.45 | 16.72 |
| Mid Cap | 37.33 | 14.23 |
| Small Cap | 29.66 | 53.38 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 1.52 | 2.73 |
| Healthcare | 91.78 | 95.78 |
| Basic Materials | 3.67 | - |
| Industrials | 1.86 | - |
| Financial Services | 1.17 | 1.48 |
Top Comparisons
HDFC Large Cap Fund - Growth Option - Regular Plan
3Y Returns15.7%
Aditya Birla Sun Life Large Cap Fund-Growth
3Y Returns15.37%
Invesco India - Invesco Pan European Equity Fund of Fund - Regular Plan - Growth Option
3Y Returns19.02%
Axis Global Innovation Fund of Fund - Regular Plan - Growth
3Y Returns25.63%
WhiteOak Capital Multi Asset Allocation Fund-Reg (G)
3Y Returns0%
Motilal Oswal Multi Asset Fund - Regular Plan - Growth Option
3Y Returns5.18%
SBI Large & MIDCap Fund- Regular Plan -Growth
3Y Returns16.58%
Mirae Asset Large & Midcap Fund - Regular Plan - Growth Option
3Y Returns17.42%